Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Doxercalciferol may be an effective way to treat localized prostate cancer before surgery. PURPOSE: Randomized phase II trial to study the effectiveness of giving doxercalciferol before surgery in treating patients who have localized prostate cancer.

Key facts

Study ID

NCT00022412

Run by

University of Wisconsin, Madison

People needed

60

Starts

2001-08-01

Expected to finish

2008-08-01

Last updated by the study team

2019-12-13

Who can join

Age: 21 and older, up to 120. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• James P. Wilmot Cancer Center at University of Rochester Medical Center — Rochester, New York, United States
• Veterans Affairs Medical Center - Madison — Madison, Wisconsin, United States
• Meriter Hospital — Madison, Wisconsin, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States
• Medical College of Wisconsin Cancer Center — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.